Dr. Jamal Razzack, M.D.
What this data tells you about Dr. Razzack
Dr. Jamal Razzack is a pulmonary disease in Houston, TX, with 20 years in practice. Based on federal Medicare data, Dr. Razzack performed 7,105 Medicare services across 2,543 unique beneficiaries.
Between the years covered by Open Payments, Dr. Razzack received a total of $12,530 from 47 pharmaceutical and/or device companies across 507 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Razzack is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Allergy skin test | 1,361 | $3 | $10 |
| Therapeutic procedures to increase strength or endurance of respiratory muscles, face to face, one on one, each 15 minutes (includes monitoring) | 695 | $8 | $11 |
| Therapeutic procedures to improve respiratory function, other than described by g0237, one on one, face to face, per 15 minutes (includes monitoring) | 695 | $8 | $12 |
| Professional services for outpatient pulmonary rehabilitation with continuous monitoring of blood oxygen, per session | 573 | $60 | $146 |
| Critical care, first 30-74 min | 490 | $171 | $358 |
| Critical care, each additional 30 minutes | 464 | $86 | $204 |
| Hospital follow-up visit, high complexity | 416 | $96 | $204 |
| Test to examine how well the lungs exchange gases | 366 | $45 | $148 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 365 | $31 | $148 |
| Test to determine lung volumes using sensors | 365 | $43 | $148 |
| Assessment of emotional or behavioral problems | 339 | $4 | $21 |
| Office visit, established patient (30-39 min) | 280 | $95 | $205 |
| Office visit, established patient, complex (40-54 min) | 232 | $140 | $280 |
| Sleep study in sleep lab (6 years or older) | 106 | $484 | $2,200 |
| Test for exercise-induced lung stress | 89 | $26 | $100 |
| Initial hospital admission, high complexity | 88 | $140 | $256 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 50 | $503 | $2,200 |
| Office visit, established patient (20-29 min) | 43 | $69 | $110 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 36 | $26 | $100 |
| Electronic analysis of neurostimulator generator with simple cranial nerve stimulator programming | 20 | $31 | $102 |
| Electronic analysis of implanted neurostimulator generator with complex cranial nerve stimulator programming | 17 | $43 | $121 |
| Sleep study including heart rate, breathing, airflow, and effort | 15 | $70 | $600 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
4.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Razzack is a remote monitoring specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (low-engagement, top 16%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Razzack experienced with allergy skin test?
Does Dr. Razzack receive payments from pharmaceutical companies?
How do Dr. Razzack's costs compare to other pulmonary diseases in Houston?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology